$Merck(MRK)$
$Merck & Co., Inc.(MRK) +0.78%: Pharma Giant Holds $144.91 as Momentum Stabilizes, Key Resistance at $149.87 Looms 📊💊
Latest Close Data: MRK closed at $144.91 (+0.78%) on Sep 17, just 7.7% below its 52-week high of $156.92. Range stayed tight at $143.50–$144.97, with pre-market at $143.54 and after-hours at $144.77.
Core Market Drivers: Daiwa upgrade in mid-August and Morgan Stanley's upgrade to Overweight (PT raised $116→$179) continue to support bullish sentiment. Moderna-Merck mRNA cancer vaccine Phase III success (INTerpath-001) reinforced Keytruda franchise durability. Defensive pharma rotation amid mixed macro tape also lent support.
Technical Analysis: Volume was 7.23M shares, below average (Volume Ratio 0.89), suggesting measured accumulation rather than breakout conviction. RSI6 at 41.58 — recovering from oversold 31.38 on Sep 9 and now neutral-bullish. RSI12 at 50.37 confirms rebalancing. MACD remains bearish: DIF 2.12 vs DEA 3.61, MACD histogram at -2.97 but narrowing, signaling early momentum inflection. KDJ shows K/D bullish cross with J at 12.40, hinting at a near-term rebound attempt.
Key Price Levels: Support at $115.80 (Sep 15 low). Strong resistance at $149.87. Immediate pivot at $143.96 (open), now reclaimed. Break above $149.87 opens path toward $156.92 high.
Valuation Perspective: P/E TTM at 113.85 looks stretched, but Forward P/E of 52.32 sits far above its historical average of 24.41 (+1 Std.Dev 45.67). P/S at 5.37 and P/B at 8.53 are premium, yet dividend yield of 2.29% provides income cushion.
Analyst Targets: 28 analysts cover MRK with average target of $150.85 (range $105–$186). Ratings: 7 Strong Buy, 16 Buy, 9 Hold — consensus leans constructive.
Weekly Outlook: Expect MRK to range between $143.50–$149.87 as bulls test resistance. Decisive close above $149.87 targets $156.92; failure to hold $143.50 opens $115.80 support. MACD histogram narrowing suggests a bullish crossover may emerge within 1–2 weeks if volume expands.
⚠️ Risk Disclaimer: This content is for informational purposes only, not financial advice. Markets involve risk. Always do your own research before making investment decisions.
🎯 $Merck & Co., Inc.(MRK) Options Strategy：Bull Call Spread
-
Underlying: MRK — Merck & Co., Inc.
-
View: Cautiously bullish / mean reversion, with momentum stabilization and potential test of $149.87 resistance; consolidation in the $143.50–$149.87 range with upside bias.
-
Strategy Type: Debit spread (defined risk, directional long)
-
Option Contract Portfolio:
-
Buy to Open: MRK 2026-09-25 145 Call @ $2.45 (mid)
-
Sell to Open: MRK 2026-09-25 150 Call @ $0.71 (mid)
-
Net Debit: $1.74 per spread (excluding commissions)
-
-
Max Gain & Loss:
-
Max Gain: [$150 – $145 – $1.74] × 100 = $326 per spread
-
Max Loss: $174 per spread (net debit paid)
-
-
Initial Cost/Credit: Debit of $1.74 per spread
Markets are always moving - and sometimes, the best move is knowing what works for you.
With Treasury yields, oil prices and rate expectations keeping markets on edge this week, investors are once again thinking carefully about where to position next. There’s no one-size-fits-all choice in investing — and the same goes for Tiger Merch. This month’s hot picks are in, featuring the Tiger Toiletry Bag, Universal Travel Adapter, Tiger Umbrella and more favourites chosen by fellow Tigers.
Explore the Monthly Hot Picks in Tiger Coin Mall, now 12% OFF for a limited time.
Comments